Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Eukaryotic translation initiation factor 4A1 pseudogene 6 (EIF4A1P6)
- Target
- EIF4A1P6
- Molecular classification
- Other (processed pseudogene)
01
Overview
Eukaryotic translation initiation factor 4A1 pseudogene 6 (EIF4A1P6) is a processed pseudogene in the human genome, homologous to the EIF4A1 gene but nonfunctional, meaning it does not encode a protein and is not involved in canonical translation initiation activities. It was first identified in 1996, is highly expressed in human primary monocytes, and has been reported in association with several diseases such as rectum cancer, multiple myeloma, schizophrenia, and hepatocellular carcinoma, though its contribution to these diseases is unknown and it is not a recognized clinical biomarker or therapeutic target[2].
- Other names
- Eukaryotic translation initiation factor 4A1P6EIF4A1P6
02
Mechanism of action
None. Since it is a non-coding pseudogene, there are no mechanisms of action for drug targeting[2].
03
Disease associations
Rectum cancer (reported, but contribution unknown)Schizophrenia (reported, but contribution unknown)Multiple myeloma (reported, but contribution unknown)Hepatocellular carcinoma (reported, but contribution unknown)
Beyond the preview
Go deeper on Eukaryotic translation initiation factor 4A1 pseudogene 6 (EIF4A1P6).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Eukaryotic translation initiation factor 4A1 pseudogene 6 (EIF4A1P6).